Liz Shea | VP, Head, IR |
Rick Gonzalez | Chairman and CEO |
Michael Severino | Vice Chairman and President |
Rob Michael | Vice Chairman, Finance and Commercial Operations and CFO |
Jeff Stewart | EVP and Chief Commercial Officer |
Laura Schumacher | Vice Chairman, External Affairs, Chief Legal Officer, and Corporate Secretary |
Chris Schott | JP Morgan |
Ronny Gal | Bernstein |
Andrew Baum | Citi |
Vamil Divan | Mizuho Securities |
Steve Scala | Cowen |
Tim Anderson | Wolfe Research |
Mohit Bansal | Wells Fargo |
Gary Nachman | BMO Capital Markets |
Geoff Meacham | Bank of America |
Josh Schimmer | Evercore |
Chris Raymond | Piper Sandler |
Matthew Harrison | Morgan Stanley |
Good morning. And thank you for standing by. Welcome to the AbbVie Fourth Quarter 2021 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions] | |
I would now like to introduce Ms. Liz Shea | Vice President - Head of Investor Relations. |
Good morning, and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Vice Chairman and President; Rob Michael, Vice Chairman, Finance and Commercial Operations and Chief Financial Officer; and Jeff Stewart, Executive Vice President, Chief Commercial Officer.
Joining us for the Q&A portion of the call is Laura Schumacher, Vice Chairman, External Affairs, Chief Legal Officer, and Corporate Secretary.
Before we get started, some statements we make today may be considered forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.